‘Biosecure Act’: New bill forces California biotech firms to cut ties with Chinese companies

Tucked inside a 3,000-page national defense bill signed into law last month is a set of new regulations that could upend the way some California biotech companies do business.

The Biosecure Act, as it is known, is focused on what it describes as “biotechnology companies of concern,” or BCCs. The legislation, contained within the National Defense Authorization Act, specifically bars biotech entities that receive federal dollars from working with companies connected to foreign adversaries ...